|
POLR3B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.73110000001309E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.87380000005177E-06 |
| Normal-vs-Stage2 |
4.749800E-01 |
| Normal-vs-Stage3 |
1.70760000028913E-07 |
| Normal-vs-Stage4 |
7.16515735632584E-12 |
| Stage1-vs-Stage2 |
4.457100E-03 |
| Stage1-vs-Stage3 |
1.210950E-01 |
| Stage1-vs-Stage4 |
4.27880000000158E-05 |
| Stage2-vs-Stage3 |
3.013900E-04 |
| Stage2-vs-Stage4 |
1.63269999997606E-06 |
| Stage3-vs-Stage4 |
1.981590E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.9371000026247E-08 |
| Normal-vs-AfricanAmerican |
5.979800E-03 |
| Normal-vs-Asian |
1.8087199999961E-05 |
| Caucasian-vs-AfricanAmerican |
3.885400E-01 |
| Caucasian-vs-Asian |
9.718400E-01 |
| AfricanAmerican-vs-Asian |
4.083200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.46809999951914E-07 |
| Normal-vs-Female |
5.43049999968126E-07 |
| Male-vs-Female |
4.804000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.89430000000035E-06 |
| Normal-vs-Age(41-60Yrs) |
1.26899999997043E-06 |
| Normal-vs-Age(61-80Yrs) |
2.170600E-04 |
| Normal-vs-Age(81-100Yrs) |
6.835900E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.975000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.710800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.373600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.105400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.838800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.657000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.772300E-04 |
| Classical-VS-Follicular |
9.84699999999616E-05 |
| Classical-VS-Other |
1.453750E-01 |
| Classical-VS-Normal |
6.86150000150931E-08 |
| Tall-VS-Follicular |
1.51579999663198E-08 |
| Tall-VS-Other |
7.595600E-01 |
| Tall-VS-Normal |
1.73909775469383E-11 |
| Follicular-VS-Other |
7.556400E-04 |
| Follicular-VS-Normal |
4.470800E-01 |
| Other-VS-Normal |
1.603620E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.030600E-04 |
| Normal-vs-N1 |
2.15705231454422E-12 |
| N0-vs-N1 |
3.67890000019244E-07 |
|
|
